Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03396341 · ClinicalTrials.gov registry record
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
A clinical trial of Genetic Testing and BRCA1/2, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 400
- Enrollment target
- 7
- Study locations
NCT03396341 is a study of Genetic Testing and BRCA1/2 that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 400 participants, below the 589-participant average among 7 other Genetic Testing trials with a reported enrollment target (32% lower). The trial reports 7 study locations across 4 states.
The verdict
NCT03396341, a study of Genetic Testing and BRCA1/2, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- OTHER Salvia sample
Study Locations (7)
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
Massachusetts
- Dana Farber Cancer Institute (Data Collection Only) - Boston
New Jersey
- Memorial Sloan-Kettering at Basking Ridge - Basking Ridge
Pennsylvania
- Abramson Cancer Center at University of Pennsylvania Medical Center (Data Collection Only) - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-01-04 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03396341
The ClinicalTrials.gov registry entry for NCT03396341 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 589-participant average among 7 other Genetic Testing trials with a reported enrollment target (32% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Genetic Testing appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT03396341 reports 7 study locations spanning 4 distinct geographic areas - top geographies include New York, Massachusetts, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03396341 about?
NCT03396341 is a clinical study titled "Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations". The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.
What is the current status of trial NCT03396341?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2018-01-04. Estimated completion is 2027-01.
What conditions does trial NCT03396341 study?
This clinical trial studies the following conditions: Genetic Testing, BRCA1/2.
What interventions are being tested in trial NCT03396341?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Salvia sample (OTHER).
Who is sponsoring clinical trial NCT03396341?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03396341 being conducted?
This trial has 7 study locations across Massachusetts, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Testing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Direct vs Indirect Methods for Cascade Screening
RECRUITING · NA
-
Addressing Genomic Disparities in Cancer Survivors
RECRUITING · NA
-
Universal Genetic Testing for Cancer Risk Reduction
RECRUITING · NA
-
Video Education With Result Dependent dIsclosure
RECRUITING · NA
-
Prospective Registry of Multiplex Testing (PROMPT)
ACTIVE NOT RECRUITING
-
Engaging Adolescents in Decisions About Return of Genomic Research Results
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.